These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39083926)

  • 21. [Reoperation for recurrent gliomas].
    Xu WL
    Zhonghua Wai Ke Za Zhi; 1992 Nov; 29(12):768-9, 799. PubMed ID: 1618041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
    Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
    Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral blood test provides a practical method for glioma evaluation and prognosis prediction.
    Wang ZL; Zhang CB; Liu YQ; Wang Z; Jiang T
    CNS Neurosci Ther; 2019 Aug; 25(8):876-883. PubMed ID: 30912613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas.
    Wang J; Xu L; Ding Q; Li X; Wang K; Xu S; Liu B
    Front Immunol; 2023; 14():1065062. PubMed ID: 37325664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma.
    Ross JL; Chen Z; Herting CJ; Grabovska Y; Szulzewsky F; Puigdelloses M; Monterroza L; Switchenko J; Wadhwani NR; Cimino PJ; Mackay A; Jones C; Read RD; MacDonald TJ; Schniederjan M; Becher OJ; Hambardzumyan D
    Brain; 2021 Feb; 144(1):53-69. PubMed ID: 33300045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of Macrophage Density in the Absence of Neutrophils in Differentiated Thyroid Cancer.
    Onuma AE; Schoenfield L; Shen C; Edwards C; Phay JE; Shirley LA; Tsung A
    J Surg Res; 2020 Dec; 256():458-467. PubMed ID: 32798993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas.
    Kone AS; Ghouzlani A; Qandouci A; Issam Salah NEI; Bakoukou Y; Lakhdar A; Karkouri M; Badou A
    Front Immunol; 2024; 15():1397486. PubMed ID: 38863709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer.
    Zhang H; Liu Z; Wen H; Guo Y; Xu F; Zhu Q; Yuan W; Luo R; Lu C; Liu R; Gu J; Ge D
    Cancer Immunol Immunother; 2022 Oct; 71(10):2511-2522. PubMed ID: 35278107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell RNA sequencing identifies a subtype of FN1 + tumor-associated macrophages associated with glioma recurrence and as a biomarker for immunotherapy.
    Xu H; Chai H; Chen M; Zhu R; Jiang S; Liu X; Wang Y; Chen J; Wei J; Mao Y; Shi Z
    Biomark Res; 2024 Oct; 12(1):114. PubMed ID: 39375795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD-L1-Mediated Immunosuppression in Glioblastoma Is Associated With the Infiltration and M2-Polarization of Tumor-Associated Macrophages.
    Zhu Z; Zhang H; Chen B; Liu X; Zhang S; Zong Z; Gao M
    Front Immunol; 2020; 11():588552. PubMed ID: 33329573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming Growth Factor Beta 2 (TGFB2) mRNA Levels, in Conjunction with Interferon-Gamma Receptor Activation of Interferon Regulatory Factor 5 (IRF5) and Expression of CD276/B7-H3, Are Therapeutically Targetable Negative Prognostic Markers in Low-Grade Gliomas.
    Trieu V; Maida AE; Qazi S
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
    Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
    J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology.
    Mehani B; Asanigari S; Chung HJ; Dazelle K; Singh A; Hannenhalli S; Aldape K
    Acta Neuropathol Commun; 2022 Feb; 10(1):19. PubMed ID: 35144680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
    Deng X; Lin D; Zhang X; Shen X; Yang Z; Yang L; Lu X; Yu L; Zhang N; Lin J
    J Cell Physiol; 2020 Oct; 235(10):7321-7331. PubMed ID: 32162312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of histopathological features of paired recurrent gliomas: a cohort study from a single cancer center.
    Li C; Xi S; Chen Y; Guo C; Zhang J; Yang Q; Wang J; Sai K; Zeng J; Wang J; Zhang Z; Ke C; Chen Z
    BMC Cancer; 2023 Jan; 23(1):8. PubMed ID: 36597096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma.
    Nejo T; Matsushita H; Karasaki T; Nomura M; Saito K; Tanaka S; Takayanagi S; Hana T; Takahashi S; Kitagawa Y; Koike T; Kobayashi Y; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Narita Y; Nagane M; Ueki K; Nishikawa R; Aburatani H; Mukasa A; Saito N; Kakimi K
    Cancer Immunol Res; 2019 Jul; 7(7):1148-1161. PubMed ID: 31088845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox Regulator
    Chang Y; Li G; Zhai Y; Huang L; Feng Y; Wang D; Zhang W; Hu H
    Front Immunol; 2020; 11():580934. PubMed ID: 33329553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas.
    Zhang H; He J; Dai Z; Wang Z; Liang X; He F; Xia Z; Feng S; Cao H; Zhang L; Cheng Q
    Front Immunol; 2021; 12():628966. PubMed ID: 33664747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prognostic Value of Preoperative Inflammatory Markers for Pathological Grading of Glioma Patients.
    Li B; Gao B; Zhu HJ; Luwor RB; Lu J; Zhang L; Kong B
    Technol Cancer Res Treat; 2024; 23():15330338241273160. PubMed ID: 39099463
    [No Abstract]   [Full Text] [Related]  

  • 40. ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.
    Xu H; Zhang A; Han X; Li Y; Zhang Z; Song L; Wang W; Lou M
    Cancer Immunol Immunother; 2022 Mar; 71(3):645-660. PubMed ID: 34313821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.